Fibrose pulmonaire idiopathique Usual interstitial pneumonia

We report the case of a 49-year old woman with an idiopathic pulmonary fibrosis (IPF) initially diagnosed as a systemic lupus erythematosus. The IPF is an uncommon clinical entity with an estimated prevalence from 3 to 6 cases per 100.000 in the general population of the United States. This disease is characterised by an insidious onset, a pejorative course and poor survival prognosis (median survival : 2,8 years). The diagnosis is often difficult and depends on the exclusion of other diseases associated with interstitial lung injury. It is generally established only after collegial coordination between the clinician, the radiologist and the pathologist. New consensuses are now published to establish a clear and explicit classification of the IPF. Moreover, because of the poor results obtained with conventional immunosuppressive drugs, new treatments are proposed.

[1]  G. Raghu,et al.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.

[2]  G. Raghu The role of gastroesophageal reflux in idiopathic pulmonary fibrosis. , 2003, The American journal of medicine.

[3]  L. Richeldi,et al.  Corticosteroids for idiopathic pulmonary fibrosis. , 2003, The Cochrane database of systematic reviews.

[4]  K. Flaherty,et al.  Corticosteroids in idiopathic pulmonary fibrosis , 2001, Current opinion in pulmonary medicine.

[5]  R. Baughman,et al.  Nonsteroidal therapy for idiopathic pulmonary fibrosis , 2001, Current opinion in pulmonary medicine.

[6]  G. Hunninghake,et al.  Idiopathic pulmonary fibrosis. , 2001, The New England journal of medicine.

[7]  D. Schroeder,et al.  High short-term mortality following lung biopsy for usual interstitial pneumonia. , 2001, The European respiratory journal.

[8]  M. Keane,et al.  Pleuropulmonary manifestations of systemic lupus erythematosus , 2000, Rheumatic diseases clinics of North America.

[9]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[10]  G. Raghu,et al.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[11]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[12]  R. Novick,et al.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.

[13]  J A Waldron,et al.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[14]  A. Katzenstein,et al.  Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance , 1994, The American journal of surgical pathology.

[15]  Demosthenes Bouros,et al.  Interferons and their application in the diseases of the lung. , 2003, Chest.

[16]  J. Cordier,et al.  Les pneumopathies interstitielles diffuses , 1988 .